• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
New research on CAR T

First Chimeric Antigen Receptor (CAR) T Cell Therapy Targeting B Cell-Activating Factor Receptor (BAFF-R) Eradicates Blood Cancers That Relapsed After CD19 CAR T Therapies

The first CAR T cell therapy targeting the B cell-activating factor receptor on cancerous cells eradicated CD19-targeted therapy-resistant human leukemia and lymphoma cells in animal models, according to City of Hope research published today in Science Translational Medicine.

Read more →
Gelymar Doubles its Production Capacity

Gelymar Doubles its Production Capacity

Gelymar S.A, the third largest carrageenan producer globally, completed this week its capacity expansion program initiated 24 months ago with a US$15M investment. Its production capacity is now doubled at about 10,000 metric tons of product.

Read more →

We use cookies to ensure you get the best experience on this website Privacy Policy